Oakland, CA, United States of America

Karan Kampani

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Roche Molecular Systems, Inc.. Active years: 2019.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Karan Kampani: Innovator in Nucleic Acid Capture Technology

Introduction

Karan Kampani is an accomplished inventor based in Oakland, CA. He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid capture technology. His innovative work has led to the development of methods that enhance the efficiency of nucleic acid capture using magnetic glass particles.

Latest Patents

Karan Kampani holds a patent titled "Successive capture of nucleic acid by magnetic glass particles." This patent outlines methods and components for the successive capture of nucleic acids, showcasing his expertise in utilizing magnetic glass particles for this purpose. He has 1 patent to his name, reflecting his commitment to advancing scientific knowledge and technology.

Career Highlights

Throughout his career, Karan has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Roche Molecular Systems, Inc. and Roche Diagnostics GmbH. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Karan has had the opportunity to work alongside talented individuals such as Sharon Legaspi and Alan Casilla. These collaborations have enriched his professional journey and fostered an environment of innovation and creativity.

Conclusion

Karan Kampani's contributions to nucleic acid capture technology exemplify his dedication to scientific advancement. His innovative patent and collaborations with esteemed colleagues highlight his role as a key figure in the biotechnology industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…